Zafgen (ZFGN) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. HALO
7. BBIO
8. SPY
9. RCKT
10. CRWV

Go back to Zafgen (ZFGN) Tops Q3 EPS by 6c

Zafgen Announces Third Quarter 2015 Financial Results

November 10, 2015 4:01 PM EST

Company to Host Conference Call at 4:30 PM Eastern Time to Review Progress with Beloranib Program

Ends Quarter with Cash, Cash Equivalents and Marketable Securities of $204 Million; Increases Year-End Cash Guidance to Greater than $180 Million

BOSTON, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced third quarter 2015 financial results and provided an update on the Companys clinical development programs, including the pivotal... More